HUPO 2025
Call for pre-congress workshop proposals
pre-congress WORKSHOP Submissions
The HUPO 2025 Core Committee invites submissions from individuals or groups to conduct Pre-Congress Workshops, which will be held on the first day of the Congress (Sunday, November 9). Workshops are 1.5 hours in length.
We welcome proposals for Pre-Congress Workshops that provide engaging and interactive forums for learning and discussion. We encourage creative proposals which go beyond the presentation of scientific research. Workshops might include practical guidance, give insight into success outside of the lab, discuss ongoing questions in proteomics or bring together communities from different fields. Industry can help with the creation of the Workshop; however, the Workshop should not be used for the promotion of commercial products.
All proposals must be submitted online. Workshop submissions are due by February 28, 2025, and submission acceptance notifications will be sent no later than Friday, March 28, 2025. Workshop space is limited, and it is likely that not all proposals can be accommodated.
Workshop proposals should include a one-page summary of the session, including:
- Description of Workshop.
- Statement regarding how the Workshop can benefit HUPO 2025 Congress attendees.
- Three main objectives for the Workshop.
- Title of the Workshop.
- Name and email of the contact person who will be responsible for Congress correspondence (If different from proposal submitter).
- Name of proposed Workshop speaker(s) with institutional affiliation and email address.
- The intended audience for the Workshop.
- Maximum number of attendees per Workshop (if applicable).
- Any special A/V needs or room set up requirements (if applicable).
- Length of Workshop (maximum 1.5 hours).
- If your Workshop proposal is accepted, the HUPO 2025 Congress will provide a session room at the Congress venue with basic AV equipment (projector, screen, microphones).
- The Congress will not be able to provide any additional financial support for additional AV expenses, speaker support or any other expenses.
- The Workshop will be listed in the program on the website, mobile app and in all official Congress materials, however, you are encouraged to personally invite people to attend the Workshop. Anyone attending the session will have to be registered for the HUPO 2025 Congress.
- It will be the organizer’s responsibility to make all arrangements for the Workshop including speaker arrangements.
- The final agenda for inclusion in the onsite materials must be submitted to the Congress Secretariat no later than August 29, 2025.
- Quality of Workshop.
- Diversity of speakers in alignment with HUPO’s Mission.
- Minimum 20% of speakers from each region (Central, Eastern, Western).
- Minimum 40% female representation.
- Engaging workshop format with interactive and educational elements.
- Potential alignment with HUPO Initiatives.
Timeline
February 28, 2025 | Proposal Submission Deadline |
March 28, 2025 | Notification of Acceptance/Decline |
August 29, 2025 | Final Program Due for Onsite Materials |
Frequently Asked Questions
Abstract titles will be released July 23, 2024.
The full abstract bodies will be released on August 14, 2024 at 10:00 PDT, except those abstracts included in the WCLC 2024 Press Program.
Abstracts selected for inclusion in the WCLC press program, including Presidential Sessions abstracts, will be kept under embargo until either the time of the presentation or the beginning of the WCLC press conference in which it is presented, whichever comes first.
An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the presentation. Submitters are required to list any previous presentations during the abstract submission process.
The submission of single case reports is not permitted, however, submission of case series with a minimum of 3 cases but preferably 5, including literature review is accepted.
July 12, 2024 is the withdrawal deadline for regular abstracts and August 9 for LBA abstracts.
The presenting author registration deadline (except LBA abstracts) is July 12, 2024 (23:59 PDT). Abstract presentations for a presenter (except LBA abstracts) not registered by this date will be withdrawn from the program.
- LBA designation will only be given to impactful prospective studies that will change clinical practice within the year and whose data are not available at the time of regular abstract submission due to study events and/or timelines. Examples include randomized phase II and/or III trials, and large single arm phase II trials in rare subtypes of thoracic malignancies. LBA’s in other disciplines that change clinical practice within the year will also be considered.
- LBA designation is not a means for extending the regular abstract deadline. Highly impactful studies that have complete data should be submitted as a regular abstract and will be considered for a prominent oral presentation based on scoring by the program committee.
- For abstracts that do not meet LBA requirements the authors will be given 48 hours to update the submitted data before the abstracts are re-classified as regular abstracts and rated based on the updated information.
Yes, industry is permitted to be in the lead and senior author positions in the author list of an abstract. However, Industry/pharmaceutical/commercial authors are prohibited from presenting Presidential, Oral, and Mini Oral presentations. Industry/pharmaceutical/commercial authors are permitted to present poster or e-poster presentations.
Associated manuscripts for any abstract selected for presentation at WCLC can be submitted to a peer reviewed journal prior to presentation at WCLC but must not be published prior to the presentation at WCLC. Simultaneous publications are encouraged.
All Regular Abstracts, Clinical Trials in Progress Abstracts, and Case Series abstracts must be fully completed by the April 5, 2024 deadline.
Any Regular Abstracts and Case Series that are incomplete after the April 5, 2024 deadline will be automatically withdrawn and will not be considered for the meeting. Clinical Trials in Progress abstracts may be submitted and completed by the April 5, 2024 deadline without Results and Conclusions as those sections are optional for CTPS submissions.
To submit a late breaking abstract, you must submit a placeholder abstract including all components of the abstract except for the Results and Conclusions by the April 5, 2024 deadline.
Authors can only be listed as the Presenting Author on two (2) abstracts but can be co-author on any number of abstracts.
There is no charge to submit an abstract to WCLC.
The authors of the abstract, however, IASLC reserves the right to sell and retain any revenue/income from selling the abstracts, presentation materials or recordings of the presentations. Please refer to the detailed terms and conditions that authors have to agree to during the abstract submission.
Copyright is with the authors, however, IASLC reserves the right to publish and sell copies/recordings of the presentation materials.
The clinical trials must be registered in clinicaltrials.gov or an applicable one from their country/regulatory body.
No. You need to attend WCLC 2024 in person to present your abstract.
No, it’s not required.
The video platform will be available for 3 months after WCLC.